Journal
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
Volume 1862, Issue 12, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.bbamem.2020.183408
Keywords
Vesicular nucleotide transporter (VNUT); slc17A9; Clodronate; Inflammation; Pain; Cancer
Categories
Funding
- Japanese Ministry of Education, Culture, Sports, Science and Technology for Scientific Research [18H02407, 17K09885]
- Grants-in-Aid for Scientific Research [18H02407, 17K09885] Funding Source: KAKEN
Ask authors/readers for more resources
Vesicular nucleotide transporter (VNUT) is the last identified member of the SLC17 organic anion transporter family, which plays a central role in vesicular storage in ATP-secreting cells. The discovery of VNUT demonstrated that, despite having been neglected for a long time, vesicular ATP release represents a major pathway for purinergic chemical transmission, which had been mainly attributed to ATP permeation channels. This article summarizes recent advances in our understanding of the mechanism of VNUT and its physiopathological roles as well as the development of inhibitors. Regulating the activity and/or the expression of VNUT represents a new and promising therapeutic strategy for the treatment of multiple diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available